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ABSTRACT 
Primary headache disorders such as migraine and tension-type headache are some of the 
most frequently-diagnosed health disorders in the world and can be extremely disabling. 
However, disability resulting from these disorders varies substantially across individuals. 
Although headache severity has been identified as the strongest predictor of headache-related 
disability, the relationship between the two variables is non-linear, suggesting that other 
mechanisms may be involved. Self-efficacy mediates relations between pain and impairment 
associated with other chronic pain conditions, but this relationship has not been evaluated in a 
sample of individuals with primary headache disorders. Therefore, the present study sought to 
examine whether headache self-efficacy acts as a mediator between headache severity and 
disability. The potential for moderated mediation by diagnostic status was also evaluated.  
The sample consisted of 822 college students with a mean age of 19.03 years (SD = 
2.19), with 378 participants (46 %) meeting International Classification of Headache Disorders, 
2
nd
 Edition diagnostic criteria for ETTH, 363 (44.2%) for episodic migraine, and 81 (9.9%) for 
chronic migraine. Headache severity and disability were strongly associated, r(818) = .61, p <  
.01. Self-efficacy mediated the association between pain severity and disability for the sample as 
a whole (95% confidence interval [CI]: .12 to .33), although the clinical significance of this 
effect may be rather modest. Moreover, the mediation effect was moderated by headache 
diagnosis such that mediation was strongest for individuals suffering from episodic migraine 
(95% CI = .12 to .43). Overall, the results indicate that both pain severity and self-efficacy 
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contribute to the extent to which an individual is disabled by their headaches. A strong belief in 
one’s own ability to manage, function in spite of, and cope with pain may protect against 
disability resulting from headache pain. The present findings build upon and extend previous 
research that has focused primarily on individuals diagnosed with chronic and/or severe 
musculoskeletal pain and extend prior findings to the cyclical pain characteristic of migraine. 
There is a need for longitudinal studies, particularly among diverse populations, assessing the 
role that headache-management self-efficacy and other potential mediators play in the experience 
of headache.
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INTRODUCTION 
Headache Disorder Diagnoses 
 According to the International Classification of Headache Disorders, 2nd Edition (ICHD-II; 
Headache Classification Subcommittee of the International Headache Society [IHS], 2004), headaches 
not attributable to identifiable organic pathology are classified as “primary” headaches; these 
headaches comprise the large majority of headaches experienced by the population. Both 
migraine and tension-type headache (TTH) are included under the category of primary headache 
disorders, which also includes less common headache subtypes such as cluster headache. 
Migraine is as a common neurological disorder characterized by recurrent severe episodes of 
headache and associated symptoms typically lasting between 4 to 72 hours. Associated 
symptoms of migraine are unilateral location, pulsating quality, moderate to severe intensity, 
aggravation by routine physical activity, nausea, and photophobia (sensitivity to light) and 
phonophobia (sensitivity to sound). In a significant minority of cases, migraine attacks are 
preceded by aura, a constellation of temporary focal neurological symptoms that are most 
commonly visual in nature (e.g., seeing spots or zigzag lines, blurry vision). Aura symptoms 
usually develop gradually over 5-20 minutes and last for less than 60 minutes, after which time 
the head pain begins (Lipton, Scher, Silberstein, Liberman, & Bigal, 2008). Among 2-3% of the 
population, migraine becomes a very frequent condition characterized by headaches on 15 or 
more days per month (i.e., chronic migraine). The rare occurrence of migraine progression from 
an episodic (< 15 days/month) to chronic (≥ 15 days/month) form, or headache “chronification,” 
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is associated with older age, female gender, significant life stressors, and overuse of acute or 
abortive headache medications (Lipton & Bigal, 2005).  
 Like migraine, TTH varies widely in frequency and duration. Tension-type headaches 
may last anywhere from 30 minutes to 7 days and occur an average of 1 day or less per month 
(infrequent episodic TTH, or ETTH), 1-14 days per month (frequent ETTH), or 15 or more days 
per month (chronic TTH or CTTH). Unlike migraine, the pain of TTH is typically bilateral, dull 
and non-throbbing, pressing or tightening in quality, of mild to moderate severity, and not 
worsened by routine activity (Rasmussen, Jensen, Schroll, & Olesen, 1991). Nausea is not 
typically associated with TTH, but photophobia or phonophobia (not both) may accompany these 
headaches, although they are typically of lesser severity compared to that observed in migraine 
(ICHD-II; Jensen, 2003). Due to frequent comorbidity and some overlap of symptoms, it has 
been suggested that migraine and TTH are actually variants of a single underlying disorder, 
existing at two different points on a continuum (Leston, 1996). However, the two headache 
forms differ in gender ratio, age distribution, and clinical presentation (Rasmussen, 1996; 
Rasmussen et al., 1991b), in turn suggesting they are in fact different disorders but with some 
similarities in presentation. 
Headache Disorder Epidemiology 
Migraine affects 12% of the population (Lipton et al., 2007) and is three times more 
common among women than men (18% vs. 6%; Fukui et al., 2008; Jelinski et al., 2006; Lipton, 
Stewart, Diamond, Diamond, & Reed, 2001; Lipton, Stewart, & Simon, 1998). In U.S. samples, 
migraine is more prevalent among Caucasian individuals than among minorities, with 20.4% of 
Caucasian women experiencing migraine in comparison to 16.4% of African-American and 
9.2% of Asian-American women. A similar trend was found among men (8.6%, 7.2%, and 4.2%, 
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respectively; Stewart, Lipton, & Liberman, 1996). Additionally, an inverse relationship has been 
established between the incidence of migraine headache and socio-economic status (SES; Lipton 
et al., 2001; Stang & Osterhaus, 1993). Migraine affects individuals of all ages, however; it is 
most prevalent between 25 and 50 years of age (Lipton et al., 2001; Jette, Patten, Williams, 
Becker, & Wiebe, 2008; Victor, Hu, Campbell, Buse, & Lipton, 2010).  
Tension-type headache is the most common of the primary headache disorders, affecting 
up to 78% of the population and being slightly more prevalent among women (42%) than men 
(36%; Jensen, 2003; Schwartz, Stewart, Simon, & Lipton, 1998). Like migraine, TTH is more 
prevalent in Caucasians than in African-Americans among both women (46.8% versus 30.9%) 
and men (40.1% versus 22.8%; Schwartz et al., 1998). An interesting difference between 
migraine and TTH is that while migraine prevalence decreases with increased SES, TTH 
prevalence increases with SES (Schwartz et al., 1998), further supporting the notion that 
migraine and TTH are in fact distinct disorders. The onset of TTH typically occurs between 20 
and 30 years of age (Gobel, Petersen-Braun, & Soyka, 1994; Rasmussen et al., 1991b; Schwartz 
et al., 1998), and prevalence peaks between 30-39 years age for both males and females 
(Schwartz et al., 1998). Tension-type headache is equally prevalent in boys and girls during 
school years. However, like migraine, TTH becomes more prevalent in females during 
adolescence (Laurell, Larsson, & Eeg-Olofsson, 2003; Milovanovic, Jarebinski, & Martinovic, 
2007). 
 Impact of Primary Headache Disorders 
  Migraine is among the 20 leading causes of disability worldwide and the 12
th
 leading 
cause of disability among women (Leonardi, Steiner, Scher, & Lipton, 2005; World Health 
Organization, 2001). Disability is a construct defined by the effect of an illness on an 
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individual’s ability to function at work as well as in other areas such as home, social, and 
familial settings (Ferrari, 1998). Studies in North America, Japan, and Europe have shown that 
during a migraine attack, individuals report a reduced ability to function (Holmes, MacGregor, & 
Dodick, 2001). During a migraine attack, approximately half of individuals are disabled to the 
point that they will require bed rest (Hu, Markson, Lipton, Stewart, & Berger, 1999; Lipton et 
al., 2001). However, functioning is not only impaired during the headache attack but also 
interictally (Clarke, MacMillan, Sondhi, & Wells, 1996; Solomon, Skobieranda, & Graff, 1993; 
Stronks, Tulen, Bussmann, Mulder, & Passchier, 2004).  
 As such, migraine affects multiple aspects of an individual’s life and confers significant 
direct and indirect costs to society as a whole (Edmeads & Mackell, 2002; Holmes et al., 2001; 
Lipton et al., 2003b; Stewart, Lipton, & Kolodner, 2003). The indirect costs of migraine are 
much higher than that of direct costs, such that indirect costs exceed $13 billion and direct costs 
$1 billion (Hu et al., 1999). As a result of indirect costs such as missing work and diminished 
productivity, many migraineurs are fearful of losing their jobs or being denied promotion (Clarke 
et al., 1996). Individuals with severe migraine have a two to four time higher rate of 
unemployment than the general population (Von Korff, Ormel, Keefe, & Dworkin, 1992). In 
addition to being less productive at work, migraineurs report that their headaches negatively 
affect their productivity at home as well as their relationships (Clarke et al., 1996; Smith, 1996), 
such that their headaches contribute to being argumentative and less involved with their partners 
and children (Lipton et al., 2003a). The negative impact of migraine extends also to school-age 
children, who miss approximately twice as many school days compared to children without 
migraine (Abu-Arefeh & Russell, 1994). Migraineurs also utilize health care services with 
greater frequency, have higher medical costs, and miss more work for health-related reasons than 
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individuals without migraine (Edmeads & Mackell, 2002; Von Korff, Stewart, Simon, & Lipton, 
1998). Finally, the impact and management of migraine is often complicated further by the 
presence of comorbid psychiatric disorders such as major depressive disorder, bipolar disorder, 
and various anxiety disorders (e.g., panic disorder, social phobia, generalized anxiety disorder; 
Baskin, Lipchik, & Smitherman, 2006; Breslau & Davis, 1993; Breslau, Lipton, Stewart, 
Schultz, & Welch, 2003; Hamelsky & Lipton, 2006; Jette et al., 2008; Oedegaard et al., 2006; 
Smoller et al., 2003; Stewart, Schechter, & Lipton, 1994). Comorbid psychiatric disorders may 
complicate differential diagnosis and are associated with reductions in quality of life and the 
effectiveness of treatment (Baskin et al., 2006; Jette et al., 2008; Lipton, Hamelsky, Kolodner, 
Steiner, & Stewart, 2000; Radat & Swendsen, 2004).  
 Although ETTH is not as severe or debilitating as migraine or CTTH, its impact on 
quality of life is still significant due to its high prevalence. The direct costs of TTH are lower 
than those of migraine, as individuals with TTH are less likely to seek medical attention 
(Rasmussen, Jensen, & Olesen, 1992). Like migraine, the treatment and management of this 
condition can be complicated by the presence of other disorders. Anxiety disorders, depressive 
disorders, and to a lesser degree somatoform disorders, are commonly comorbid with TTH 
(Heckman & Holroyd, 2006; Puca et al., 1999). The prevalence of TTH is greatest during adults’ 
peak productive years, and thus resulting disability is often significant. Approximately 8% of 
those with ETTH report missing work due to headache and 44% report being less effective at 
home, work, or school due to headache (Schwartz, Stewart, & Lipton, 1997). Schwartz and 
colleagues (1997) found that while migraine patients have higher rates of absenteeism from 
work, TTH accounts for a higher proportion of reduced productivity at work. Like migraine, the 
impact of TTH extends beyond work and into school performance as well, as university students 
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with ETTH experience an average of 2.3 days of pain per month and greater impairment than 
those without headache (Bigal, Bigal, Betti, Bordini, & Speciali, 2001).  
Impact of Pain Severity on Disability 
As in other chronic pain conditions, significant variability exists in the extent to which an 
individual is disabled by headache (Lipton et al., 2002). In order to understand why pain causes 
greater impairment in some individuals than others, identifying the factors that are most strongly 
associated with pain-related disability is imperative. Not surprisingly, pain severity has been 
found to be one of the strongest predictor of disability in a variety of chronic pain conditions 
including headache (Arnstein, 2000; Arnstein, Caudill, Mandle, Norris, & Beasley, 1999; Ford, 
Calhoun, Kahn, Mann, & Finkel, 2008; Leonardi, Raggi, Bussone, & D’Amico, 2010; Levin, 
Lofland, Cassisi, Poreh, & Blonsky, 1996; Magnusson & Becker, 2003; Rejeski, Craven, 
Ettinger Jr., McFalane, & Shumaker, 1996). In a study examining the effects of headache 
severity and frequency on disability experienced by migraineurs, pain severity was a stronger 
predictor of headache-related disability than headache frequency (Magunusson & Becker, 2003).  
Though pain severity is a strong predictor of disability, other factors are likely involved. Indeed, 
regression analyses have shown that the relationship between pain severity and pain-related 
disability is non-linear, suggesting that other contributing factors may affect disability associated 
with chronic pain (Magnusson & Becker, 2003; Rucker & Metzler, 1995; Serlin, Mendoza, 
Nakamura, Edwards, & Cleeland, 1995; Stewart et al., 2003). A considerable body of research 
supports Magnusson and Becker (2003) in their assertion that psychosocial factors such as self-
efficacy beliefs likely contribute to the disability experienced by chronic pain sufferers (Ciccone, 
Just, & Bandilla, 1996; Nicholson, Hursey, & Nash, 2005; Turk, Okifuji, Starz, & Sinclair, 
1996).  
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The Role of Self-Efficacy in Headache  
 Broadly, self-efficacy is defined as an individual’s perception of (or confidence in) his or 
her ability to perform specific behaviors in certain contexts (Bandura, 1977a; Bandura, 1977b). 
Social learning theory asserts that individuals are more likely to engage, persist, and endure in 
behaviors that they believe will be successful (Bandura, 1977b). When applied to the 
management and prevention of pain, individuals with high self-efficacy are most likely to be 
confident in their ability to engage in adaptive coping skills. These individuals will subsequently 
be less likely to utilize pain-management and prevention skills they have acquired and to persist 
in their efforts to cope with their pain. Meanwhile, those who have lower levels of self-efficacy 
are less likely to be confident in their ability to manage their pain and subsequently cease pain 
management attempts in the absence of quick results, instead relying more readily upon 
medication for management of their condition (Bandura, O’Leary, Taylor, Gauthier, & Gossard, 
1987; O’ Leary, 1985).  
 As in other pain conditions, successful management and treatment of headache is 
dependent upon the patient’s level of self-efficacy (Holroyd, Penzien, Rains, Lipchik, & Buse, 
2008; Martin, Holroyd, & Rokicki, 1993; Nicholson et al., 2005). Using a cold-pressor task, Litt 
(1988) found that perceived level of self-efficacy affected pain tolerance and was predictive of 
how an individual would respond in the presence of aversive stimuli. Furthermore, increased 
self-efficacy predicts improved outcomes in a variety of chronic pain conditions. Self-efficacy is 
correlated with the increased efficacy and utilization of pain-coping skills, as well as increased 
physical and emotional functioning in individuals suffering from chronic joint pain disorders 
(Lefebvre et al., 1999; Rejeski et al., 1996; Sharma, Cahue, Song, Hayes, Pai, & Dunlop, 2003). 
In patients suffering from chronic pain in the lower back or limbs, self-efficacy is correlated with 
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improved functioning, improved treatment outcomes, lower levels of pain, and lower ratings of 
disease severity (Kores, Murphy, Rosenthal, Elias, & North, 1990; Lacker, Carosella, & 
Feuerstein, 1996; Levin et al., 1996). Finally, in treating fibromyalgia patients, pre-treatment 
ratings of self-efficacy and changes in pre- to post-treatment self-efficacy were found to be 
predictive of better outcomes, as increased self-efficacy was associated with reduced disease 
severity, and pain intensity and increased physical ability (Buckelew et al., 1996).  
 Self-efficacy has been established as a reliable predictor of headache-related outcomes 
(Martin, Holroyd, & Rokicki, 1993; Nicholson et al., 2005). Self-efficacy also appears to 
underlie the efficacy of behavioral headache interventions. One of the most historically effective 
treatments of TTH is electromyographic (EMG) biofeedback training. The traditional 
explanation for the effectiveness of these procedures attributed decreased headache activity to 
physiological mechanisms involving relaxation of the pericranial muscles, prolonged 
contractions of which were implicated in causing TTH (Budzynski, Stoyva, Adler, & Mullaney, 
1973). This physiological explanation, both for the efficacy of biofeedback and the mechanism 
of TTH, has since been discredited by studies showing that improvement in TTH via EMG 
biofeedback training alone or in combination with relaxation is mediated by changes in levels of 
self-efficacy (Blanchard, Kim, & Cu, 1993; Holroyd et al., 1984; Rokicki et al., 1997). In the 
Holroyd et al. study, self-efficacy predicted improvements in TTH even among patients who 
were trained to actually increase (versus decrease) their muscle tension during EMG 
biofeedback. In essence, the improvements resulting from EMG biofeedback were found to be 
the product of the cognitive changes stemming from performance feedback (of success) rather 
than changes in EMG activity.  
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 Similar results have been found in other treatment studies of TTH. Holroyd and 
colleagues (2009) reported that the significant improvements in headache activity resulting from 
stress-management therapy alone or in combination with antidepressant medication were fully 
mediated by headache self-efficacy, regardless of headache severity. In addition, self-efficacy 
change resulting from the use of antidepressant medication alone had little role in the reduction 
of headache, providing evidence that the purported self-efficacy mediation was not simply the 
result of reduced headache frequency and intensity. Contrary to these findings, Seng and 
Holroyd (2010) found that the use of a beta-blocker for migraine prophylaxis was associated 
with increases in self-efficacy regardless of headache severity, although there were no significant 
differences between the changes in headache self-efficacy associated with the use of a beta-
blocker versus use of a placebo. One proposed explanation for this finding is that the 
effectiveness of pharmacological migraine treatments results more from the act of taking 
medication rather than the medication’s pharmacological effects. Seng and Holroyd (2010) found 
that behavioral therapy increased self-efficacy more than medication and the greatest increases in 
self-efficacy were attained when behavioral treatment was combined with medication. These 
studies support Bandura’s assertion (1977a) that changes resulting from psychological (and 
perhaps medication) treatments are largely dependent on the procedure’s ability to alter an 
individual’s level of self-efficacy. 
Headache, Self-Efficacy, and Disability 
 Given the number of studies highlighting the associations between high self-efficacy and 
reductions in pain-related impairment, as well as strong evidence that behavioral headache 
treatments are effective because they strengthen self-efficacy beliefs, potential interactions 
between headache severity and headache self-efficacy should be examined. The present model 
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hypothesizes that the relationship between headache pain and headache disability is mediated by 
self-efficacy. If this model holds true, it would provide an explanation as to why headache 
treatments that increase self-efficacy levels are also effective in reducing headache-related 
disability, regardless of the pain severity experienced by the patient. Moreover, if confirmed, this 
model would provide support for a mechanism by which headache pain affects disability 
(MacKinnon, Fairchild & Fritz, 2007).  
 This basic model has been validated in several studies among samples of chronic pain 
patients. Self-efficacy has been found to act as a mediator between pain severity and disability in 
two studies of the physical and psychosocial components of pain (Arnstein et al., 1999; Arnstein, 
2000). More recently, this mediational relationship has been confirmed in a sample of chronic 
low-back pain patients (Costa, Maher, McAuley, Hancock, & Smeets, 2011). These findings 
yield support for the proposed relationships between pain severity, self-efficacy, and disability 
resulting from pain. Furthermore, they imply that low self-efficacy contributes to disability even 
in the presence of only mild to moderate pain. However, most participants in previous studies 
have reported suffering from pain in the lower back, extremities, or midsection. Therefore, 
further research is needed to understand whether this model applies specifically to individuals 
suffering from primary headache disorders. 
 Preliminary support for the application of this model to those with primary headache 
disorders was provided when French and colleagues (2000) observed that headache self-efficacy 
was negatively correlated with both headache-related disability and headache severity among a 
sample of 329 CTTH sufferers. Though their study did not directly address the mediational 
model proposed by Arnstein and colleagues (1999 & 2000), it does confirm the basic premises 
that pain severity and self-efficacy are predictive of disability among headache patients. Their 
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findings do not address temporal relations among the variables, nor the applicability of these 
findings to other headache diagnoses; thus, the extent to which this model holds across different 
primary headache diagnoses remains unknown. Headache diagnosis may moderate the degree to 
which self-efficacy mediates the relationship between pain severity and disability, given 
differences in severity, symptomatology, and disability among ETTH, episodic migraine (EM; 
with and without aura), and chronic migraine (CM).  
Aims of the Present Study 
The principal goal of the present study is to examine whether headache self-efficacy 
mediates relations between pain severity and headache-related disability in a non-clinical sample 
of young adult headache sufferers. The present study also seeks to examine whether the strength 
of the proposed mediational role of self-efficacy differs by headache diagnosis. College students 
serve as an ideal population in which to assess these variables because of their high prevalence of 
headache (25% migraine prevalence: Smitherman, McDermott, & Buchanan, 2011; 33% ETTH: 
Bigal et al., 2001) and because their relatively short headache histories rarely are complicated by 
medication overuse or chronification.  
Goals & Hypotheses 
The following study goals and hypotheses are proposed:  
Study Goal 1: To examine whether headache pain severity is associated with headache-related 
disability across diagnoses.  
Figure 1: Proposed direct relationship between headache severity and headache disability.  
 
Severity Disability 
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Hypothesis 1: Headache severity will be significantly and positively correlated with disability 
regardless of headache diagnosis. 
Study Goal 2: To examine whether headache self-efficacy acts as a mediator between headache 
severity and headache-related disability.  
Figure 2: Proposed mediational model with headache self-efficacy as the mediator.  
 
Hypothesis 2: Self-efficacy will at least partially mediate relations between pain severity and 
headache-related disability.  
Study Goal 3: To examine whether headache diagnosis moderates any observed mediation effect 
of self-efficacy. 
Figure 3: Proposed moderated-mediation model with headache diagnosis as the moderator.  
Self Efficacy 
Severity Disability 
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Hypothesis 3: The strength of the relationship between headache self-efficacy and headache 
disability is moderated by headache diagnosis, such that the meditational role of self-efficacy 
will be strongest in individuals with CM, followed by EM and finally ETTH. 
Self Efficacy 
Severity Disability 
Diagnosis 
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METHODS 
Participants 
 Participants were undergraduate students enrolled in introductory psychology courses. 
Students were eligible if they were 18 years of age or older and fulfilled ICHD-II diagnostic 
criteria for CM, EM (with or without aura), or ETTH. ICHD-II criteria were followed strictly 
with the one exception that the minimum required duration of migraine was shortened from 4 
hours to 2 hours in light of data showing that younger adult migraineurs often experience 
otherwise prototypical migraine attacks that are shorter than 4 hours (Rains, Penzien, Lipchik & 
Ramadan, 2001; Rasmussen, Jensen, & Olesen 1991). Assuming a moderate effect size (f
2
 = 
0.15), a power level of 0.8, and an alpha level of 0.05, a total sample size of 148 was required 
(Fritz & MacKinnon, 2007). 
Materials 
Demographic Questionnaire. Participants provided information pertaining to age, 
gender, marital status, race, employment status, level of education, income, religion, Greek 
status, relationship status, as well as mother and father’s level of education.  
Structured Diagnostic Interview for Headache – Revised. The Structured Diagnostic 
Interview for Headache – Revised (SDIH-II) is a structured headache diagnostic interview that 
assesses the presence of primary headache disorders in strict accordance with ICHD-II criteria. 
The 17 items inquire about headache type, frequency, pain severity, and other diagnostic 
characteristics and symptomatology. The instrument also provides information about the 
experience of aura symptoms and cluster headaches and can be used to rule out secondary causes 
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such as post-traumatic headache (i.e., directly attributable to a head injury) and medication 
overuse. The original SDIH has been found to accurately identify migraine in both clinical and 
non-clinical populations (Andrew, Penzien, Rains, Knowlton, & McAnulty, 1992) and was 
modified slightly for the present study to adhere to ICHD-II diagnostic criteria and to be 
administered in a computerized format. This measure can be found in Appendix A. 
Headache Management Self-Efficacy Scale-25. The Headache Management Self-
Efficacy Scale-25 (HMSE-25; French et al., 2000) is a self-report instrument that quantifies an 
individual’s perceived ability to prevent or manage her headaches. The scale is made up of 25 
questions that are rated on a 7-point Likert-type scale with responses ranging from “strongly 
disagree” to “strongly agree”. Nine of the items are reverse-scored. Higher scores are indicative 
of higher levels of self-efficacy. Scores range from 25 to 175. The HMSE has demonstrated 
excellent internal consistency (  = .90) and construct validity via a positive correlation with 
Headache Specific Locus of Control Scale (HSLC; Martin, Holroyd, & Penzien, 1990) Internal 
Subscale (r = 0.40) and a negative correlation with the HSLC Chance subscale (r = -0.64) 
(French et. al, 2000). These findings suggest that individuals who score high on the HMSE are 
confident in their ability to manage and prevent their headaches and are less likely to believe 
their headaches are the result of chance (French et. al, 2000). This measure can be found in 
Appendix B. 
Headache Impact Test-6. The Headache Impact Test-6 (HIT-6; Kosinski et al., 2003) is 
a 6-item self-report measure of the impact of headache on an individual’s functioning. The 
instrument addresses how social functioning, cognitive functioning, and psychological distress 
are affected by headache. Each question requires the respondent to provide an estimate of 
frequency of impairment (over the last 4 weeks) on a 5-point Likert-type scale ranging from 
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“never” to “always”. Scores range from 36 to 78. This score provides a basis for organizing 
respondents into 4 levels of severity ranging from little or no impact to very severe impact. 
Headaches are seen as having little impact on an individual who scores 49 or less, some impact 
on those scoring 50-55, substantial impact on those scoring 56-59, and a very severe impact on 
those scoring 60 or more. The HIT-6 has shown good internal consistency ( = 0.90) and test-
retest reliability (r = 0.78; Kosinski et al., 2003) as well as discriminant validity across headache 
diagnostic groups. This measure can be found in Appendix C. 
Procedure 
 The aforementioned measures were included as part of a larger online survey battery. 
Students completed the online battery over three consecutive semesters and received modest 
course credit for their participation.  
Statistical Analyses  
 Statistical analyses were conducted for participants who had complete data for all 
variables of interest. Before beginning the primary analyses, bivariate correlations between 
measures were tested using Pearson correlation analyses. The primary analyses were then 
conducted in three steps. First, the effects of headache severity on headache disability through 
self-efficacy were assessed, both directly and indirectly using standard path-analytic approaches 
described by Preacher and Hayes (2004, 2008) and MacKinnon (2008). Second, given the 
presence of a mediation effect, the extent to which the effect of self-efficacy on disability was 
moderated by headache diagnosis was estimated using a moderated ordinary least-squares (OLS) 
regression analysis (Hayes, 2013; Hayes & Mathes, 2009). Finally, mediation and moderation 
results were combined by estimating the conditional indirect effects of severity on disability 
through self-efficacy as a function of headache diagnosis, using the moderated-mediation 
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approach (Hayes, 2013; Preacher, Rucker, & Hayes, 2007). Because the proposed moderator 
(headache diagnosis) was categorical, two dummy variables were created in order to code for the 
three-category diagnostic group variable. Gender was included as a covariate in the model due to 
findings suggesting that women report greater pain severity and disability scores than men 
(Bayliss et al., 2003; Stewart et al., 1994). The required criterion for statistical significance for 
each analysis was p < .05.  
 Preacher and Hayes’ (2004, 2007, & 2008) approaches were chosen because they utilize 
a bootstrapping approach. Briefly, bootstrapping is a procedure that takes a predetermined 
number of samples from the original data set via random sampling with replacement. The 
indirect effect of each of the bootstrap samples is computed and tests of significance are 
conducted using a percentile-based confidence interval (95% CI) computed around these 
estimates of the indirect effect. To date, no consensus has been reached regarding the optimal 
number of bootstrap samples that should be generated. According to Preacher and Hayes (2008), 
5,000 samples should be used for final reporting. Although it is likely that fewer samples would 
have been sufficient, for the purpose of this study, 5,000 were generated in order to minimize 
sampling variance.  
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RESULTS 
Participant Demographics and Headache Diagnosis Prevalence 
 A total of 3613 students participated. Two-hundred eighty-one failed to complete the 
entire battery, 533 did not complete the headache-specific items necessary to render a valid 
headache diagnosis, and 323 evidenced suspect effort by taking less than 30 minutes to complete 
the 600+ items in the battery (i.e., ≥ 90th percentile of completion time speed; see Meade & 
Craig, 2012 and Smitherman & Kolivas, 2013). These participants were excluded from analyses, 
as were students who denied headache (n = 644), reported symptoms indicative of probable 
migraine (n = 426) or probable TTH (n = 356), or reported suffering from CTTH (n = 26), 
cluster headache (n = 31), or secondary headache attributable to head injury or medication 
overuse (n = 95). Finally, 76 participants were missing subscale scores on at least one of the 
measures of interest. As is standard in the estimation of path analytic models, these participants 
were also excluded from analyses (Chen, Aryee, & Lee, 2005; Preacher & Hayes, 2004) based 
on the reasoning that it would be misleading to present a “directional” model based on analyses 
of paths that were derived from different subsets of the data.   
Table 1 presents the demographic characteristics of the sample. The sample consisted of 
822 college students (71.2% female) with a mean age of 19.03 years (SD = 2.19). The majority 
(78.7%) of the sample was Caucasian, 16.1% were African-American, 2.4% were 
Hispanic/Latino, 1.6% were Asian, 0.9% identified as multiracial, and 0.3% were Native 
American/Pacific Islander. With regard to headache diagnosis, of the retained sample 378 
participants (46 %) met ICHD-II diagnostic criteria for ETTH, 363 (44.2%) met the diagnostic 
 19 
 
criteria for EM (252 (30.7%) without aura and 111 (13.5%) with aura), and 81 (9.9%) met the 
criteria for CM. Participants reported experiencing headache 6.55 days per month (SD = 5.08), 
and average headache severity for the sample was 4.84 out of 10 (SD = 1.76). Participants 
reported a mean self-efficacy score of 111.10 (SD = 20.60) on the HMSE-25 and a mean score of 
Table 1 
 
 Demographic Characteristics of the Sample  
 
Variable       % or Mean (SD) 
Gender (% Female)  71.2 
       
Mean Age (SD)   19.03 (2.19) 
       
Race (% Caucasian)  78.7 
       
Marital Status (% Never Married) 97.9 
       
Education (% Some college)  55.6 
       
Employment (% Unemployed) 77.2 
       
Income (% >$50,000)  38.3 
       
Greek (% Greek)   32.0 
       
Religion (% Protestant/Evangelical) 55.8 
       
Relationship (% In Relationship) 38.5 
       
Father's Education (% ≥ bachelor’s degree) 62.0 
       
Mother’s Education (% ≥ bachelor’s degree) 61.0 
       
Mean Headache Severity (SD) 4.84 (1.76) 
       
Mean HMSE Score (SD)  111.10 (20.60) 
      
Mean HIT-6 Score (SD)      53.10 (9.13) 
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53.10 (SD = 9.13) on the HIT-6. Although approximately 39% of the sample reported 
experiencing little to no disability as a result of their headaches, nearly 40% endorsed substantial 
to very severe headache disability. 
Data Analytic Assumptions 
Histograms, Q-Q plots, and descriptive statistics (i.e., skewness, kurtosis) were used to 
assess data analytic assumptions for the variables of interest (SDIH-II pain severity scale, 
HMSE-25, HIT-6) and found to be satisfactory. All participants were assessed for multivariate 
outliers on the main total scores of interest by using Mahalanobis distance; two multivariate 
outliers (both CM) were found using a conservative p < .001 cutoff and were removed prior to 
subsequent analyses.  
Although the distributional assumptions of the data were found to be satisfactory, 
Preacher and Hayes’ (2004, 2007, 2008) bootstrapping techniques differ from traditional 
methods of meditational analyses in that they do not impose assumptions of normality 
(MacKinnon et al., 2007).  The percentile-based CIs used in bootstrapping are based on 
empirical estimations of the sampling distribution, rather than the traditional assumption that the 
sampling distribution is normal. Therefore, percentile-based CIs can be (and often are) 
asymmetrical. Bias-corrected and accelerated CIs are reported when possible based on the 
assertion by MacKinnon and colleagues (2004) that the percentile-based CI can be further 
improved through bias-correction and acceleration, which adjust for both bias and skew. 
Although it is beyond the scope of this paper, a detailed and technical account justification of 
these methods is provided by Efron (1987) and Efron and Tibishirani (1993).  
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Correlations among the Variables under Study 
Significant correlations were found between each of the variables. Headache severity 
showed a moderate negative association with headache self-efficacy, r(818) = -.30, p <  .001, 
and showed a strong positive correlation with headache-related disability, r(818) = .61, p <  .001, 
providing preliminary support for the first hypothesis. Higher reported headache self-efficacy 
was associated with lower levels of headache-related disability, r(818) = -.32, p < .001. As to be 
expected in a mediational analysis, all of the variables were at least moderately correlated. 
Therefore, a large sample size was obtained to minimize the impact of conceptual overlap. 
Mediation Analysis 
Using the INDIRECT procedure for SPSS (Preacher and Hayes, 2008), the effect of headache 
severity on disability was assessed directly and indirectly through self-efficacy. Each path is 
represented in terms of an unstandardized OLS regression coefficient. As depicted in Table 2, 
after controlling for gender, a total effect of headache severity on headache disability was 3.07, p 
< .001, further confirming that headache disability is greater for individuals who experience 
more severe headache pain. For every one-point increase in headache severity, HIT-6 scores 
increased by more than three points on average. The direct effect of headache severity on 
headache disability was 2.85, p < .001. Holding self-efficacy constant, a one-unit increase in 
headache severity was associated with a 2.85 unit increase in disability (HIT-6 scores). 
 Most relevant to the mediation hypothesis was the estimate of the indirect effect of 
headache severity on disability through self-efficacy. This effect was quantified as the product of 
two OLS regression coefficients, one estimating self-efficacy from pain severity (path a in 
Figure 4) and the other estimating headache disability from self-efficacy controlling for severity  
(path a in Figure 4) and the other estimating headache disability from self-efficacy controlling 
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Table 2 
Regression results for indirect effect 
      95% CI 
Predictor Pathway B SE T p LL UL 
Constants IM 130.96 3.02 43.29 <.01 125.02 136.89 
 IY 42.54 1.99 21.38 <.01 38.64 46.45 
HMSE on:        
Severity a -3.42 .39 -8.76 <.01 -4.18 -2.65 
 R
2
 = .09  - - <.01 - - 
Disability 
on: 
       
     HMSE b -.06 .01 -4.96 <.01 -.09 -.04 
Severity c’ 2.85 .15 19.29 <.01 2.56 3.14 
     Gender  2.18 .55 3.98 <.01 1.10 3.26 
Indirect 
via: 
       
     HMSE ab .22 .05 - <.05 .12 .33 
Total c 3.07 .14 19.29 <.01 - - 
 R
2
 = .41  - - <.01 - - 
*Note. CI = confidence interval; LL = lower limit; UL = upper limit; HMSE = headache 
management self-efficacy. 
for severity (path b in Figure 4). Path a indicates that a unit increase in headache severity was 
associated with a 3.42 unit decrease in self-efficacy (a = -3.42), and path b indicates that a unit 
increase in self-efficacy was associated with a reduction in disability of .06 units (b = .06). As 
reported in Table 2, the difference between the total and direct effects is the indirect effect 
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through self-efficacy, which has a point estimate of .22 (95% CI = .12 - .33). As this bias-
corrected and accelerated bootstrap CI did not include zero, the null hypothesis that the total 
indirect effect is zero was rejected, as the mediation effect was found to be significant at α < 
0.05. These results indicate that little of the variance in self-efficacy is explained by changes in 
headache severity (R
2 
= .093); however, more than forty percent of variance in HIT-6 scores is 
accounted for by both self-efficacy and headache severity (R
2 
= .405). These results provide 
support for the hypothesis that headache pain severity is associated with headache-related 
disability partially through headache self-efficacy.  
Figure 4: Path coefficients for simple mediation analysis on headache-related disability 
 
Note: c denotes the total effect while c’ denotes the effect of headache severity on disability when self-
efficacy is not included as a mediator. Gender was included as a covariate but is not represented here.  
** p < .01 
 
 
Moderation of the Effect of Self-Efficacy on Disability by Diagnosis 
 The mediation analysis provided evidence of a positive indirect effect of headache 
severity on disability through headache-management self-efficacy, with higher headache severity 
associated with lower self-efficacy, which in turn was related to a higher level of headache-
related disability. Hypothesis 3 predicted that the indirect effect of headache severity would be 
Self Efficacy 
Severity Disability c’ = 2.85**; SE = .15 
c = 3.07**; SE = .14 
a = -3.42**; SE = .39 b = -.06**; SE = .01 
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moderated by headache diagnosis, such that any observed mediation via self-efficacy would be 
stronger for individuals with migraine than for those with TTH.  
To test for moderation of the effect of self-efficacy on disability by headache diagnosis, 
an SPSS macro was utilized to generate an OLS regression model predicting disability from self-
efficacy, headache diagnosis, and their products (along with gender as a control variable) using 
5,000 bootstrapped estimates for the construction of a 95% bias-corrected CI coefficient (Hayes, 
2013; Hayes & Mathes, 2009). This method produced calculations of the effect of self-efficacy 
on disability for individuals with specific headache diagnoses. Table 3 presents the results of an 
OLS regression model testing the hypothesis that the path between self-efficacy and disability 
(path b in Figure 4) was moderated by headache diagnosis.  
As mentioned earlier, the three headache diagnoses were coded using two dummy 
variables. As depicted in Figure 5, when EM was coded as 1 and CM was coded as 0, a 
bootstrapped estimate of path b
4
 was calculated for EM. When EM was coded as 0 and CM was 
coded as 1, a bootstrapped estimate of path b
5
 was calculated for CM. When both variables were 
coded as 0, a bootstrapped estimate of path b
1
 was calculated for ETTH. The regression 
coefficients for self-efficacy and diagnosis are conditional effects with their products in the 
model and can be found in Table 3.  As expected, the interaction for individuals with ETTH was 
not significantly different from zero (b1 = -.02, p = .18), indicating that when holding constant 
headache severity among individuals with ETTH, those with relatively low self-efficacy were no 
more disabled than those higher in self-efficacy. In contrast, the interaction for EM was 
significant (b4 = -.054, p = .03) and accounted for .3% of the variance in disability. Last, the 
interaction for CM was non-significant (b5 = -.035, p = .42), accounting for only .04% of the  
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Table 3 
Regression results for conditional effect of self-efficacy on disability.  
 95% CI 
Predictor Pathway B SE T p LL UL 
Constants Iy 40.13 2.39 16.80 <.01 35.44 44.82 
HMSE b -.02 .02 -1.33 .18 -.06 .01 
EM b
2 
10.85 2.92 3.71 <.01 5.12 16.59 
CM b
3
 10.54 4.62 2.28 .02 1.47 19.61 
Interaction 1 
(EM) 
b
4
 -.05 .03 -2.12 .03 -.10 >-.01 
Interaction 2 
(CM) 
b
5
 -.04 .04 -.81 .42 -.12 .05 
Severity c’ 2.03 .17 11.96 <.01 1.69 2.36 
Gender  1.65 .53 3.11 <.01 .61 2.68 
Effect of SE on 
Disability for: 
       
ETTH  -.02 .02 -1.33 .18 -.06 .01 
EM  -.08 .02 -4.20 <.01 -.11 -.04 
CM  -.06 .04 -1.46 .14 -.14 .02 
Severity  2.03 .17 11.96 <.01 1.69 2.36 
R
2
 increase due 
to interactions: 
R
2
 change F df1 df2 p   
EM .003 4.48 1 812 .03   
CM .0004 .65 1 812 .42   
Both .003 2.26 2 812 .10   
*Note. Interaction 1 = HMSE x EM; Interaction 2 = HMSE x CM. 
 26 
 
variance. These results indicate that the effect of self-efficacy on disability is negative and 
significant for those with EM (point estimate = -0.08, 95% CI = -0.11 – -0.04), whereas the 
effect of self-efficacy on disability is not significantly different from zero for individuals with 
CM (point estimate = -0.06, 95% CI = -0.14 – 0.02) and ETTH (point estimate = -0.02, 95% CI = 
-0.06 – 0.01).    
 Figure 5: Path coefficients for moderated mediation analysis on headache-related 
disability  
 
Note, Conditional indirect effect of X on Y through M = a(b1+b4V+b5Q). Direct effect of X on Y = c’ 
 
 
 The direct effect (c’) quantifies how much two individuals who differ by one unit in 
headache severity are estimated to differ in disability when holding constant both self-efficacy 
and diagnosis. As displayed in Table 3, the direct effect was positive and significant (c’ = 2.03, p 
Self Efficacy 
Severity 
Disability EM 
CM 
Gender 
EM-SE 
Interaction 
CM-SE 
Interaction 
a 
b1 
c’ 
b2 
b3 
b4 
b5 
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< .01). Thus, two individuals differing by one unit in headache severity but equal in headache 
self-efficacy and with the same diagnosis are expected to differ by 2.03 units on the HIT-6, such 
that higher headache severity is associated with greater disability.  
Moderated Mediation 
 As evidenced previously, the simple mediation analysis established that headache severity was 
positively associated with disability through headache-management self-efficacy. Headache 
severity was associated with lower self-efficacy, which in turn was associated with higher 
disability scores. The moderation analysis showed that the effect of self-efficacy was contingent 
upon diagnosis, with the effect of self-efficacy being significant for those with EM only. 
Considered together, these findings provide evidence of moderated mediation. The indirect effect 
of headache severity on disability is contingent upon diagnosis. However, to this point, it is 
unclear whether the indirect effects differ from zero for individuals with differing headache 
diagnoses. In order to examine this interaction, indirect effects were calculated at specific values 
of the moderator using the methods outlined by Hayes (2013) and Preacher and colleagues 
(2007). The point estimates and 95% CIs for the conditional indirect effect can be found in Table 
4. For individuals with ETTH, the conditional effect of self-efficacy on disability was not 
significantly different from zero (point estimate = .08, 95% CI: -.03 to .21). Differentially, for 
both EM (point estimate = .26, 95% CI: .12 to .43) and CM (point estimate = .20. 95% CI: .0009 
- .43), the conditional indirect effect was significant. Thus, regardless of an individual’s 
diagnosis, those with higher self-efficacy tended to be less disabled by their headaches, as the 
conditional effects for each diagnosis were all positive. However, this effect was statistically 
significant only for individuals with migraine, and the effect was largest for those with EM.  
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Table 4 
Conditional indirect effect regression coefficients 
 95% CI 
Indirect 
Effect for: 
Pathway B SE T p LL  UL 
ETTH ab
1 
.08 .06 - >.05 -.03 .21 
EM ab
2 
.26 .08 - <.05 .12 .43 
CM ab
3 
.20 .11 - <.05 <.01 .43 
 R
2 
.46 - - <.01 - - 
 
Given that the indirect effect was significantly different from zero for migraineurs but not 
for individuals with ETTH, a secondary analysis was implemented to examine whether the 
conditional indirect effect for one diagnostic group was statistically different from the 
conditional indirect effect for another diagnostic group. As shown at the bottom of Figure 5, the 
conditional indirect effect of headache severity is equal to a(b1+b4V+b5Q), where V = EM and Q 
= CM. For the purpose of this analysis, both diagnosis variables were dummy-coded; therefore V 
= 1 for individuals with EM and V = 0 for all other diagnoses. Similarly, Q = 1 for individuals 
with CM and Q = 0 for all other diagnoses. Thus, 95% confidence intervals can be calculated 
utilizing the following equations to determine whether statistically significant differences exist 
between each of the diagnostic groups in terms of the conditional indirect effect of headache 
severity on disability through self-efficacy: 
Equation 1 = EM v. CM: ab1(0)+ab4(1)+ab5(0) - ab1(0)+ab4(0)+ab5(1) 
ab4(1)+ab5(0)- ab4(0)+ab5(1) 
or 
ab4- ab5 
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Equation 2 = EM v. ETTH: ab1+ab4(1)+ab5(0)- ab1(1)+ab4(0)+ab5(0) 
or 
ab4- ab1 
Equation 3 = CM v. ETTH: ab1+ab4(0)+ab5(1)- ab1(1)+ab4(0)+ab5(0) 
or  
ab5- ab1 
The indirect effect for the EM groups was slightly but not significantly greater than that of both 
the CM group, with a point estimate of .06 (95% CI = -.20 - .32), and the ETTH group (point 
estimate = .10; 95% CI = -.17 - .36). Further, the CM group was slightly but not significantly 
greater than the ETTH group (point estimate = .04, 95% CI = -.28 - .36). Although the indirect 
effect of headache severity on disability through self-efficacy differed significantly from zero for 
migraineurs, the indirect effect does not differ significantly between diagnostic groups. This 
finding is supported by the finding that R
2
 changed only minimally when interactions between 
diagnosis and disability were added to the model (Table 3).    
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DISCUSSION 
The present study sought to examine how headache severity is associated with headache-
related disability. Although previous studies have examined this question in samples of chronic 
musculoskeletal pain patients (Arnstein, 2000; Arnstein et al., 1999; Costa et al., 2011), the 
present study extends these findings by examining the role of self-efficacy as a potential 
mediator among a sample of individuals suffering from headache disorders. Further, the present 
study builds upon previous research by examining whether the proposed mediational relationship 
differs as a function of headache diagnosis and by utilizing updated statistical methodology for 
assessing mediation.  
Self-Efficacy as a Mediator 
As hypothesized, a significant positive bivariate correlation was found between severity 
and disability. This finding is consistent with previous research (Arnstein, 2000; Ford et al., 
2008; Leonardi et al., 2010; Magnusson & Becker, 2003) and indicated the presence of an effect 
to be mediated. Although these data were not collected among individuals who were presenting 
for headache treatment, a significant number were significantly impaired by their condition. 
Many individuals reported headache pain that interfered with home or family responsibilities, 
occupation, school, and social activities.  
A mediation analysis showed that the positive association between headache severity and 
disability was driven in part by headache management self-efficacy. This finding is supported by 
previous cross-sectional and longitudinal studies of individuals with chronic muskuloskeletal 
pain (Arnstein et al. 1999; Arnstein, 2000; Costa et al., 2011). Individuals with higher self-
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efficacy scores were less disabled than individuals with lower self-efficacy scores, even if 
ratings of pain severity were held constant. Findings were significant even after controlling for 
gender, which was as a significant predictor of disability in this study as well as in previous 
research (Bayliss et al., 2003). This finding builds upon Bandura’s theories (1977a; 1977b) and 
recent research indicating that a belief in personal efficacy is adaptive in coping with pain (Costa 
et al., 2011; Holroyd et al., 2008; Vancleef & Peters, 2011). These findings extend the 
conclusions of previous chronic pain studies by showing that headache sufferers, similar to 
individuals suffering from chronic musculoskeletal pain, may experience disability in part due to 
the belief that they can do little to prevent or reduce their pain.  
Despite the statistical significance of self-efficacy as a mediator, the clinical significance 
of this mediation effect is questionable. Less than 10% of the variance in self-efficacy was 
explained by headache severity (R
2
 = .093), whereas 41% of the variance in headache disability 
was accounted for by both self-efficacy and headache severity, similar to the results reported by 
Arnstein and colleagues (1999; 2000). However, there is a substantial amount of unexplained 
variance in disability that is attributable to some other processes or mechanisms not included in 
the model. According to Castien and colleagues (2012), a clinically significant reduction in HIT-
6 scores is at least 8 points (on a total range of 42). Given the relatively modest indirect effect of 
headache severity on disability through self-efficacy, changes in self-efficacy resulting from 
changes in disability are not likely to produce clinically significant changes in headache 
disability. Therefore, clinically meaningful changes in disability may be attained more via 
interventions that influence pain severity directly or via interventions that influence pain 
severity’s effect on disability through some mediator not included in the present model.  
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Despite the significant but rather modest meditational effects of self-efficacy in the 
present study, the development of self-efficacy remains a major component of behavioral 
headache interventions. Many headache patients benefit from behavioral treatments designed to 
increase self-efficacy, either as an alternative to or in conjunction with pharmacological 
treatments. Behavioral treatments of migraine have been shown to produce increases in self-
efficacy and headache activity (Holroyd et al., 2008; Nestoriuc, Martin, Rief, & Andrasik, 2008) 
and may hold particular benefits for those who possess low levels of headache-management self-
efficacy. Headache treatment studies examining self-efficacy frequently utilize headache 
activity, specifically frequency, severity, and duration as outcome variables. These studies show 
that improvements in self-efficacy frequently are associated with improvements in headache 
activity (Blanchard et al., 1993; Holroyd et al., 1984; Holroyd et al., 2009; Rokicki et al., 1997).  
Given that self-efficacy is associated with both headache activity and disability, an important 
empirical inquiry would be which outcome variable is most strongly associated with self-
efficacy. Further, certain subgroups of headache sufferers may benefit from treatments that 
address psychological factors other than self-efficacy (Holroyd et al., 2009). Emotional distress, 
pain-related anxiety, depression, headache-related locus of control beliefs, and stress are 
associated with increased disability (French et al., 2000; Nash et al., 2006) and reduced response 
to headache treatments (Holroyd et al., 2009), although these variables were not assessed in the 
present study.  
The modest role of self-efficacy conflicts somewhat with a large body of research 
asserting that self-efficacy is a very strong predictor of disability and other deleterious clinical 
outcomes resulting from primary headache disorders and other chronic pain conditions (Arnstein 
et al., 1999; Bandura, 1977a; Holroyd et al., 2009; Martin et al., 1993; Nicholson et al., 2005; 
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Somers, Wren, & Shelby, 2012).  However, these findings are based on samples composed 
primarily of treatment-seeking patients, and few studies have examined the causal effects of self-
efficacy on pain-related disability (Arnstein, 2000; Arnstein et al., 1999; Costa et al., 2011; 
Holroyd et al., 2008). As the present study examined a non-clinical sample of individuals 
primarily reporting episodic pain of mild to moderate severity (Hirschfeld & Zernikow, 2013), 
the role of self-efficacy was compared across headache diagnostic groups.   
Headache Diagnosis as a Moderator  
Individuals with TTH typically experience pain that is not as severe as that experienced 
by migraineurs (Lipton et al., 2008; Rasmussen et al., 1991). Further, in comparison to 
migraineurs, those with ETTH are not as disabled by their pain (Bigal et al., 2001; Fuh, Wang, 
Lu, Liao, Chen, & Yang, 2010). As self-efficacy is negatively correlated with both pain severity 
and disability (French et al., 2000; Nicholson et al., 2005), it was predicted that as a group 
individuals with ETTH would report higher self-efficacy than individuals with migraine and that 
self-efficacy beliefs would be less relevant among those with ETTH versus migraineurs. 
 Consistent with this hypothesis, after controlling for headache severity, self-efficacy was 
associated with disability for those with EM but not CM or ETTH. In contrast, a significant 
mediation effect was observed among individuals with both EM and CM such that higher 
headache severity was associated with lower disability via change in self-efficacy among 
individuals with migraine. Thus, while self-efficacy scores may be relatively high among 
individuals with ETTH, high self-efficacy does not appear to buffer them from the deleterious 
effects of headache pain. These findings extend prior research (French et al., 2000; Holroyd et 
al., 2009) by demonstrating that the association between self-efficacy and disability is not 
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significant for all headache sufferers, indicating the need to consider not only how disability 
occurs, but also under what circumstances. 
The finding of moderated mediation (i.e., that self-efficacy’s effect on disability was 
contingent upon diagnosis) may be explained by reference to social learning theory (Soderlund 
& Asenlof, 2010). After repeated failures in their attempts, individuals with very frequent 
headache may come to believe that they can do little to prevent and manage their pain and thus 
fail to engage in necessary coping strategies (Bandura, 1977b). Therefore, self-efficacy may act 
as a buffer for those with EM but not CM. Finally, headache diagnosis may not be the most 
useful moderator variable, given overlap between diagnostic symptoms of migraine and TTH 
and frequent comorbidity between the two diagnoses (Marcus, 1992; Turkdogan, Cagirici, 
Soylemez, Sur, Bilge, & Turk, 2006). Variables such as headache frequency or the presence of 
psychopathology such as anxiety or depression, both of which are more common among 
individuals with more chronic headache conditions (Bigal Sheftell, Rapoport, Tepper, Weeks, & 
Baskin, 2003; Breslau & Davis, 1993; Lipton & Bigal, 2005; Swartz, Pratt, Armenian, Lee, & 
Eaton, 2000), may more strongly influence the relationship between self-efficacy and disability. 
Limitations and Future Directions 
Strengths of the current study included a large sample size composed entirely of primary 
headache sufferers and strong statistical methodology. However, some limitations are worth 
bearing in mind when drawing conclusions from the current study. The present study is cross-
sectional; therefore, even significant associations among variables should be interpreted as 
correlational rather than causal due to uncertainty regarding the temporal ordering of the 
variables. For example, although it was assumed that reductions in self-efficacy lead to greater 
disability for headache patients, individuals with greater disability may perceive their actions as 
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less effective. Despite uncertainty regarding the temporal ordering of the variables in the present 
study, hypotheses were based on well-established research suggesting that self-efficacy predicts 
pain-related disability (Lacker, et al., 1996; Sharma et al., 2003) and mediates important health 
outcomes (Bandura, 1977b, O’Leary, 1985; Holden, 1991). Nevertheless, until studies are 
completed where self-efficacy is experimentally manipulated, causality cannot be assumed. 
Although self-efficacy is significantly associated with headache disability, the magnitude of the 
relationship, which is critical to the evaluation of self-efficacy’s theoretical and clinical utility, 
remains unclear and varies across studies. Studies implementing behavioral interventions 
designed to increase self-efficacy would be useful in examining whether changes in self-efficacy 
are able to produce clinically significant changes in disability per se.  Future studies utilizing 
structural equation modeling or the longitudinal methods outlined by MacKinnon and colleagues 
(2007) are needed to establish the presence and direction of cause-effect relationships among the 
various interrelated facets of headache pain.  
Second, though the sample was large, it was a convenience sample with limited diversity. 
While the finding that the majority of the sample was comprised primarily of women was 
expected (Fukui et al., 2008), diversity in race and age was limited. Nonetheless, the mean 
ratings of headache severity (M = 4.82), self-efficacy (M = 110.99), and disability (M = 53) 
obtained in the present study are consistent with previous studies of individuals diagnosed with 
primary headache disorders (Bayliss et al., 2003; French et al., 2000; Kosinski et al., 2003; 
Lipton et al., 2007 Rasmussen et al., 1991); therefore, conclusions drawn from this study are 
likely to be representative of primary headache sufferers as a population. However, replication 
with treatment-seeking samples and more diverse participants would further inform the proposed 
relationships, as these conclusions may not apply to treatment-seeking individuals. Future studies 
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may also build upon the findings of the present study by examining individuals with primary 
headache diagnoses other than those examined here (e.g. CTTH, cluster headache).  
Third, despite the fact that our mediation model was significant, future research is needed 
that examines other potential mediators and moderators of the relationship between severity and 
disability. Headache-related control beliefs, emotional distress, pain-related anxiety, and 
headache frequency are other variables that merit examination as potential mediators of the 
relationship between headache pain severity and disability. Headache-related locus of control, or 
the attribution of headaches and headache relief to oneself, health professionals, or chance, is 
associated with headache disability (Martin et al., 1990), as are negative affective states (French 
et al., 2000; Holroyd et al., 2009; Nash, Williams, Nicholson, & Trask, 2006; Trask, Iezzi, & 
Kreeft, 2001), with one study finding that that pain-related anxiety was a stronger predictor of 
headache disability than self-efficacy (Nash et al., 2006).  
Significant advancements have been made in the area of statistical analyses for mediation 
and moderation but have yet to be regularly implemented in the field of chronic head pain. The 
tools and macros discussed in this article are freely available to researchers and allow for 
efficient analysis even when the model consists of a large number of variables. Therefore, in 
addition to examining new variables and how they contribute to headache disability, future 
research should employ new theoretical models such as those proposing multiple mediators 
(Preacher & Hayes, 2008). Such models may account for a greater amount of variability in 
disability than the present model and would afford comparisons between proposed mediators in 
terms of which variables contribute most heavily to headache disability.  
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APPENDIX A: STRUCTURED DIAGNOSTIC INTERVIEW FOR HEADACHE- 
REVISED  
 54 
 
Structured Diagnostic Interview for Headache – Revised 
 
1. Do you ever get headaches? 
 a. Yes  b. No 
 
2. On average, how many DAYS PER MONTH do you have a headache? 
 _____ days 
 
3. How long have your headaches been occurring at this rate? 
 _____ months  OR _____years 
 
4. If 0 is no pain, 5 is moderate pain, and 10 is the worst pain imaginable, what is the average pain 
intensity of these headaches (pick one number between 0 and 10)? 
 _____ 
 
5. If left untreated or unsuccessfully treated, about long would these headaches usually last? 
 _____ hours   
 
6. For approximately how long have you had these headaches?  
 _____ months   OR  _____ years  
 
7. About how many of these headaches have you had in your life? 
 a. Less than 5 
 b. 5 – 10 
 c. 11 – 20 
 d. More than 20 
 
8. Which of the following best describes your pain? 
 a. Pulsating/Throbbing b. Tight pressure (non-pulsating) 
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9. Is the pain typically experienced on one side or both sides of your head? 
 a. Typically one side  b. Typically both sides 
 
10. Is the pain made worse by routine physical activities or cause you to avoid routine physical activities 
(like walking, bending over, or climbing stairs)?  
 a. Yes  b. No 
 
11. Do you often feel nauseous or sick to your stomach during these headaches? 
 a. Yes  b. No 
 
12. Do you often vomit or throw up during these headaches? 
 a. Yes  b. No 
 
13. Are you often sensitive to light during these headaches? 
 a. Yes  b. No 
 
14. Are you often sensitive to sound during these headaches? 
 a. Yes  b. No 
 
15. Do you often experience any symptoms before the headache pain actually begins, such as changes in 
your vision (blurry vision, seeing spots or lines), changes in your sensation (numbness, tingling), or 
changes in your speech? 
 a. Yes 
 b. No  
 
16. How many times have you experienced these symptoms before having a headache? 
 a. 1 
 b. 2 – 5 
 c. 6 – 10 
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 d. More than 10 
 
17. Do you use any medications to treat these headaches? 
 a. Yes 
 b. No 
 
18. If you use medication, how many days per week do you use any type of medication to treat your 
headaches? 
 a. Less than 1 day per week 
 b. 1-2 days per week 
 c. 3 days per week 
 d. 4 or more days per week 
 
19. How long have you been using these medications at this frequency? 
 a. 3 months or less 
 b. More than 3 months 
 
20. Did your headache develop or get worse when you started using these medications at this frequency? 
 a. Yes 
 b. No 
 
21. Did this headache develop shortly after a head injury or head trauma? 
 a. Yes 
 b. No 
 
22. Have you ever been diagnosed with cluster headaches? 
 a. Yes 
 b. No 
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23. Do these headaches interfere with your work, school, or personal life? 
 a. Yes 
 b. No 
 
24. Which of the following trigger (cause) your headaches? (Select ALL that apply) 
 a. Stress 
 b. Menstruation 
 c. Noise 
 d. Odors/smells 
 e. Not eating 
 f. Alcohol 
 g. Weather changes 
 h. Not getting enough sleep 
 i. Sleeping too much or too long 
 j. Exercise 
 k. Sexual activity 
 l. Smoking  
 m. None of these trigger my headaches 
 
25. From the list of triggers below, which of the following is the MOST important in causing your 
headaches? (Select ONLY one) 
 a. Stress 
 b. Menstruation 
 c. Noise 
 d. Odors/smells 
 e. Not eating 
 f. Alcohol 
 g. Weather changes 
 h. Not getting enough sleep 
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 i. Sleeping too much or too long 
 j. Exercise 
 k. Sexual activity 
 l. Smoking  
 m. None of these trigger my headaches 
 
26.   If you encountered this most important trigger, what are the chances (0 - 100% likelihood) that you 
would get a headache? (pick one number between 0 – 100%) 
 _____ % 
 
27.    In a typical 30-day month, on how many days would you usually encounter this most important 
trigger? (pick one number between 0 and 30 days)  
 _____ days
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APPENDIX B: HEADACHE MANAGEMENT SELF-EFFICACY SCALE-25 
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HMSE-25 
 
Instructions: You will find below a number of statements related to headaches. Please read each 
statement carefully and indicate how much you agree or disagree with the statement by circling a number 
next to it. Use the following scale as a guide: 
 
Strongly 
Disagree 
Moderately 
Disagree 
Slightly 
Disagree 
Neither Agree 
or Disagree 
Slightly 
Agree 
Moderately 
Agree 
Strongly 
Agree 
1 2 3 4 5 6 7 
 
1)  I can keep even a bad headache from disrupting my day by changing the 
way I respond to the pain. 
1     2     3     4     5     6      7 
2) * When I’m in some situations, nothing I do will prevent headaches.* 1     2     3     4     5     6      7 
3)  I can reduce the intensity of a headache by relaxing. 1     2     3     4     5     6      7 
4)  There are things I can do to reduce headache pain. 1     2     3     4     5     6      7 
5)  I can prevent headaches by recognizing headache triggers. 1     2     3     4     5     6      7 
6)  Once I have a headache there is nothing I can do to control it.* 1     2     3     4     5     6      7 
7)  When I’m tense, I can prevent headaches by controlling the tension. 1     2     3     4     5     6      7 
8)  Nothing I do reduces the pain of a headache.* 1     2     3     4     5     6      7 
9)  If I do certain things every day, I can reduce the number of headaches I 
will have. 
1     2     3     4     5     6      7 
10)  If I can catch a headache before it begins I often can stop it. 1     2     3     4     5     6      7 
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Please complete reverse side 
 
Strongly 
Disagree 
Moderately 
Disagree 
Slightly 
Disagree 
Neither Agree 
or Disagree 
Slightly 
Agree 
Moderately 
Agree 
Strongly 
Agree 
1 2 3 4 5 6 7 
 
 
 
11)  Nothing I do will keep a mild headache from turning into a bad headache.* 1     2     3     4     5     6      7 
12)  I can  prevent  headaches by changing how I respond to stress. 1     2     3     4     5     6      7 
13)  I can do things to control how much my headaches interfere with my life. 1     2     3     4     5     6      7 
14)  I cannot control the tension that causes my headaches.* 1     2     3     4     5     6      7 
15)  I can do things that will control how long a headache lasts. 1     2     3     4     5     6      7 
16)  Nothing I do will keep a bad headache from disrupting my day.* 1     2     3     4     5     6      7 
17)  When I’m not under a lot of stress I can prevent many headaches. 1     2     3     4     5     6      7 
18)  When I sense a headache is coming, there is nothing I can do to stop it. * 1     2     3     4     5     6      7 
19)  I can keep a mild headache from disrupting my day by changing the way I 
respond to the pain. 
1     2     3     4     5     6      7 
20)  If I am under a lot of stress there is nothing I can do to prevent 
headaches.* 
1     2     3     4     5     6      7 
21)  I can do things that make a headache seem not so bad. 1     2     3     4     5     6      7 
22)  There are things I can do to prevent headaches. 1     2     3     4     5     6      7 
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23)  If I am upset there is nothing I can do to control the pain of a headache.*  1     2     3     4     5     6      7 
24)  I can control the intensity of headache pain. 1     2     3     4     5     6      7 
25)  I can do things to cope with my headaches. 1     2     3     4     5     6      7 
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